J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Announces Target Price $197

Futu NewsNov 21 20:34 · Ratings

J.P. Morgan Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT)

TipRanksNov 21 20:10 · Ratings

Express News | Sarepta Therapeutics Inc : JP Morgan Cuts Target Price to $197 From $202

BreakingsNov 21 00:23

S&P 500 Futures Climb In Premarket Trading; Target, Fabrinet Lag

Dow JonesNov 20 20:30

Barclays Initiates Sarepta Therapeutics(SRPT.US) With Buy Rating, Announces Target Price $209

Futu NewsNov 20 19:31 · Ratings

High Alpha Stocks That Are Rated 'Overweight' – MS

Seeking AlphaNov 20 03:40